MRI contrast enhancement of necrosis by MP-2269 and gadophrin-2 in a rat model of liver infarction

Investigative Radiology

Volumn 36, Issue 2, 2001, Pages 97-103

  Ni, Yicheng ^a   Adzamli, Kofi ^b   Miao, Yi ^a   Cresens, Erwin ^a   Yu, Jie ^a   Periasamy, Muthunabar Peri ^b   Adams, Max D ^b   Marchal, Guy ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Albumin binding; Contrast media; Metalloporphyrins; MRI; Necrosis

Indexed keywords

GADOPHRIN 2; MP 2269; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG HALF LIFE; DRUG PROTEIN BINDING; IMAGE QUALITY; INFARCTION; LIVER ISCHEMIA; LIVER NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION; TISSUE DISTRIBUTION;

EID: 0035128069     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200102000-00005     Document Type: Article

References (32)

1. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice
2. Tetra-p-amonophenylporphyrin conjugated with Gd-DTPA: Tumor-specific contrast agent for MR imaging
3. Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers
4. Localization of metalloporphyrin induced "specific" enhancement in experimental liver tumors: A comparison between MRI, microangiographic and histologic findings
5. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis
6. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: Experimental results
7. Paramagnetic metalloporphyrins: Infarct-avid contrast agents for diagnosis of acute myocardial infarction by magnetic resonance imaging
8. Paramagnetic metalloporphyrins: From enhancers for malignant tumors to markers of myocardial infarcts
9. Localization and determination of infarct size by Gd-mesoporphyrin-enhanced MRI in dogs
10. Validation of intracoronary delivery of metalloporphyrin as an in vivo "histochemical staining" for myocardial infarction with MR imaging
11. Myocardial viability
12. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent
13. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats
14. MRI of myocardial infarction
15. Contrast-enhanced MRI for quantification of myocardial viability
16. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model
17. Evaluation of interventional liver tumor ablation with Gd-mesoporphyrin-enhanced magnetic resonance imaging
18. Mechanism of gadophrin-2 accumulation in tumor necrosis
19. NMRD assessment of the interaction of MP-2269 with albumin
20. Synthesis and preliminary evaluation of MP-2269, a novel, nonaromatic small-molecule blood-pool MR contrast agent
21. Magnetic resonance imaging, microangiography, and histology in a rat model of primary liver cancer
22. Paramagnetic metalloporphyrins: There exist necrosis-avid and non-avid species
23. Necrosis-avid contrast agents: Introducing nonporphyrin species
24. Transport of molecules in the tumor interstitium: A review
25. Leaky tumor vessels: Consequences for tumor stroma generation and for solid tumor therapy
26. 99mTc-complex to tumor tissue
27. Delivery of molecular and cellular medicine to solid tumors
28. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
29. Targeted relaxation enhancement agents for MRI
30. Phosphonate-modified GdDTPA complexes, III: The detection of myocardial infarction by MRI
31. Pilot MR evaluation of pharmacokinetics and relaxivity of specific blood pool agents for MR angiography
32. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: Relevance to MR angiography